2 results about "Intestinal type" patented technology

Disclosed is use of Cordyceps sinensis MBF1 in the preparation of a health product or drug for preventing and / or treating radiation injury, particularly in the preparation of a health product or drug for preventing and / or treating intestinal radiation injury and / or hematopoietic radiation injury caused by ionizing radiation. Cordyceps sinensis MBF1 can significantly ameliorate symptoms caused by intestinal radiation injury, such as shortened colon length, small intestinal tissue injury, and elevated small intestinal inflammation level, ameliorate symptoms caused by hematopoietic radiation injury, such as reduced white blood cell count, reduced spleen index, and / or reduced thymus index, and can be used as a health product or drug for preventing and treating radiation injury, particularly intestinal radiation injury and / or hematopoietic radiation injury, thereby addressing the current lack of effective health products or drugs for the clinical treatment of intestinal radiation injury and / or hematopoietic radiation injury. In addition, the present disclosure provides a new idea and strategy for developing an anti-radiation injury health product or drug and demonstrates important scientific significance and clinical application value.

Disclosed is use of Cordyceps sinensis in the preparation of a health product or drug for preventing and / or treating radiation injury, particularly in the preparation of a health product or drug for preventing and / or treating intestinal radiation injury caused by ionizing radiation. Specifically, Cordyceps sinensis can significantly ameliorate symptoms caused by intestinal radiation injury, such as weight loss, shortened colon length, elevated ROS content in blood and / or small intestine, elevated inflammation levels in blood and / or small intestine, and small intestine tissue injury.